A novel bromodomain inhibitor, CPI-203, serves as an HIV-1 latency-reversing agent by activating positive transcription elongation factor b

作者：Taizhen Liang, Xuanxuan Zhang, Fangyuan Lai, Jian Lin, Chenliang Zhou, Xinfeng Xu, Xing-hua Tan, Shuwen Liu, Lin Li · 发表于：Biochemical Pharmacology · 年份：2019 · DOI：10.1016/j.bcp.2019.04.005 · 被引用次数：29 · 研究领域：HIV Research and Treatment、Protein Degradation and Inhibitors、HIV/AIDS drug development and treatment